Biomarkers of infection for the differential diagnosis of pleural effusions

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1383-1389

  Porcel, J M ^a   Vives, M ^b   Cao, G ^a   Bielsa, S ^a   Ruiz onzalez A ^a   Martinez Iribarren A ^a   Esquerda, A ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b Division of Internal Medicine   (Spain)

Author keywords

C reactive protein; Empyema; Lipopolysaccharide binding protein; Pleural effusion; Procalcitonin; Triggering receptor expressed on myeloid cells

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PH; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CARRIER PROTEINS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PLEURAL EFFUSION; PROTEIN PRECURSORS; PULMONARY MEDICINE; RECEPTORS, IMMUNOLOGIC;

EID: 71549160091     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00197208     Document Type: Article

References (22)

1. Christ-Crain M, Müller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007; 30: 556-573.
2. Rahman NM, Davies RJO. Effusions from infections: parapneumonic effusion and empyema. In: Light RW, Gary Lee YC, eds. Textbook of Pleural Diseases. Hodder Arnold, London, 2008; pp. 341-366.
3. Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008; 15: 581-587.
4. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008; 213: 701-713.
5. Yilmaz Turay U, Yildirim Z, Türköz Y, et al. Use of pleural fluid Creactive protein in diagnosis of pleural effusions. Respir Med 2000; 94: 432-435.
6. García-Pachon E, Llorca I. Diagnostic value of C-reactive protein in exudative pleural effusions. Eur J Intern Med 2002; 13: 246-249.
7. Kiropoulos TS, Kostikas K, Oikonomidi S, et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med 2007; 101: 910-918.
8. Chierakul N, Kanitsap A, Chaiprasert A, et al. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004; 9: 66-69.
9. Garcia-Pachon E, Soler MJ, Padilla-Navas I, et al. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis. Respiration 2005; 72: 486-489.
10. Daniil ZD, Zintzaras E, Kiropoulos T, et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J 2007; 30: 957-964.
11. Chen SC, Chen W, Hsu WH, et al. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema. Lung 2006; 184: 141-145.
12. Porcel JM, Galindo C, Esquerda A, et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology 2008; 13: 58-62.
13. Liu CL, Hsieh WY, Wu CL, et al. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med 2007; 101: 903-909.
14. Chan MC, Chang KM, Chao WC, et al. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 2007; 12: 333-338.
15. Kim JH, Park EY, Kim WH, et al. Soluble triggering receptor expressed on myeloid cells-1: role in the diagnosis of pleural effusions. Tuberc Respir Dis 2007; 62: 290-298.
16. Sim YS, Lee JH, Chun EM, et al. Diagnostic utility of pleural fluid soluble triggering receptor expressed on myeloid cells 1 in patients with exudative pleural effusion. Tuberc Respir Dis 2007; 62: 499-505.
17. Huang LY, Shi HZ, Liang QL, et al. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin Med J (Engl) 2008; 121: 1656-1661.
18. Bishara J, Goldberg E, Ashkenazi S, et al. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Ann Thorac Surg 2009; 87: 251-254.
19. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36: 941-952.
20. Topolcan O, Holubec L, Polivkova V, et al. Tumor markers in pleural effusions. Anticancer Res 2007; 27: 1921-1924.
21. Lin MC, Chen YC, Wu JT, et al. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest 2009; 136: 205-211.
22. Gaïni S, Koldkjaer OG, Pedersen C, et al. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006; 10: R53.